대장·직결장암 | 바이오정보모아

ADCBiologicstalePfizerderuxtecan and tucatinibPhase 3

Tucatinib (Tucatinib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 100%임상시험 57상태 RECRUITING

CGTBiologicstaleNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5

임상시험 54상태 ACTIVE

CGTBiologicOno Pharmaceutical Co., Ltd.Phase 3

tegafur-gimeracil-oteracil potassium (tegafur-gimeracil-oteracil potassium)

Gastric Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase3#인기#세포유전치료+5

임상시험 54상태 RECRUITING

ADCBiologicstaleDaiichi Sankyoderuxtecan (T-DXd) in FISH-…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, DS-8201a)

Colorectal Neoplasm · Malignant Neoplasm of Breast

#MalignantNeoplasmofBreast#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 74.1%임상시험 53상태 DISCONTINUED

AntibodystaleJanssenderuxtecan, datopotamab der…Phase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+5

효능 ORR 4.3%임상시험 51상태 RECRUITING

ADCBiologicstaleAmgenbiodistributionPhase 2

Sotorasib (Sotorasib)

Colorectal Cancer; Resectable Colorectal Carcinoma · Locally Advanced Lung Non-Small Cell Car

#LocallyAdvancedLungNon-SmallCell#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 0%임상시험 51상태 RECRUITING

AntibodystaleGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3

임상시험 45상태 RECRUITING

CGTBiologicstaleViroMissile, Inc.foreignPhase 1

oncolytic vaccinia virus (IDOV-Immune, IDOV-Immune (oncolytic vaccinia virus))

Colorectal Cancer; Pancreatic Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+5

효능 ORR 80%임상시험 40상태 RECRUITING

ADCBiologicstaleMirati Therapeutics Inc.biodistributionPhase 3

Adagrasib (Adagrasib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4

효능 ORR 31.9%임상시험 38상태 RECRUITING

AntibodystaleGruppo Oncologico del Nord-OvestPhase 2

Botensilimab (Botensilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3

임상시험 38상태 RECRUITING

CGTBiologicstaleAbbVievedotin (RC48) with the est…Phase 2

Granulocyte Colony-Stimulating Factor (Granulocyte Colony-Stimulating Factor)

AML, Childhood; Aml · AML, Childhood

#AMLChildhood#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 20.4%임상시험 32상태 RECRUITING

AntibodystaleGilead SciencesPhase 2

Magrolimab (Magrolimab)

Solid Tumor; Colorectal Cancer · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+4

효능 ORR 66.7%임상시험 30상태 DISCONTINUED

ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 69.3%임상시험 30상태 ACTIVE

AntibodystalePfizerPhase 1

sasanlimab (sasanlimab)

Carcinoma, Pancreatic Ductal; Colorectal Neoplasms · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase1#항체#면역항체+5

효능 ORR 33.3%임상시험 23상태 DISCONTINUED

ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 2

HS-20093 (HS-20093)

Advanced Solid Tumor · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 22상태 RECRUITING

CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 19상태 ACTIVE

ADCBiologicstaleBioMed Valley Discoveries, IncPhase 2

Ulixertinib (Ulixertinib)

Metastatic Colorectal Cancer · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 2%임상시험 18상태 RECRUITING

ADCBiologicstaleShanghai JMT-Bio Inc.Phase 2

KN026 (KN026)

HER2-positive Colorectal Cancer; HER2-positive Biliary Tract Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 17상태 RECRUITING

ADCBiologicstaleAstraZenecaPhase 2

Danvatirsen (Danvatirsen)

Advanced Colorectal Carcinoma; Advanced Lung Non-Small Cell Carcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 11.1%임상시험 14상태 RECRUITING

CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

Anti-CEA-CAR T (Anti-CEA-CAR T)

Lung Cancer; Colorectal Cancer · CEA

#CEA#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 13상태 ACTIVE

2 / 9 페이지

← 이전 다음 →

갱신 기록 없음 · 14일 주기 · 방문 320 / 4,954